When we added monocyte count, neutrophil count, and C-reactive protein to the fully adjusted models, the effect sizes of NWO on postmenopausal breast cancer were attenuated by 3.74%, 11.23%, and 19.25%, respectively (Supplementary Table 4). The gene discussed is CRP; the disease is breast carcinoma.